FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 331:678 September 8, 1994 Number 10 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

To the Editor: The recent article by Fanaroff et al. on the use of intravenous immune globulin to reduce nosocomial infections in very-low-birth-weight infants (April 21 issue)¹ is the largest published study of the use of this intervention in this population. The study was conducted in two phases; phase 1 was blinded, and phase 2 was not. The authors report on outcomes such as the incidence of confirmed nosocomial infection and septicemia in the treated and control groups in each phase and in both phases combined. They also report on the statistical analysis of the two phases combined.

Because the . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.